MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37 | -15.9% | 3,814 | +4.4% | 0.00% | – |
| Q2 2023 | $44 | -66.2% | 3,655 | -60.9% | 0.00% | – |
| Q1 2023 | $130 | +176.6% | 9,350 | +181.4% | 0.00% | – |
| Q4 2022 | $47 | -95.3% | 3,323 | +8207.5% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 40 | -60.4% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 101 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -76.9% | 101 | -67.6% | 0.00% | – |
| Q4 2021 | $13,000 | -99.9% | 312 | -99.9% | 0.00% | -100.0% |
| Q3 2021 | $17,273,000 | -75.9% | 351,950 | -79.5% | 0.02% | -76.2% |
| Q2 2021 | $71,722,000 | -40.1% | 1,718,721 | -48.9% | 0.08% | -44.8% |
| Q1 2021 | $119,795,000 | +25.0% | 3,361,267 | -1.6% | 0.14% | +19.8% |
| Q4 2020 | $95,799,000 | – | 3,415,297 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |